on 18 Oct 2024
Last Applicant/ Owned by
Viridian Therapeutics, Inc.
6200 Lookout RoadBoulder, CO 80301
US
Serial Number
2090230 filed on 09th Mar 2021
Correspondent Address
SUITE 2600, 160 ELGIN STREETOTTAWA
ONTARIO
CA
K1P1C3
Vienna Information
1 . 1 . 1
StarsÉtoiles
1 . 1 . 2
One starUne étoile
1 . 1 . 10
Stars with more than four pointsÉtoiles à plus de quatre pointes
26 . 3 . 23
Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.
27 . 3 . 1
Letters or numerals representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an objectLettres ou chiffres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet
27 . 3 . 12
Letters or numerals representing a heavenly body or a natural phenomenonLettres ou chiffres représentant un corps céleste ou un phénomène naturel
27 . 1 . 1
Letters or numerals forming geometrical figures, written or typographical matter in perspectiveLettres ou chiffres formant des figures géométriques, inscriptions en perspective
27 . 1 . 6
Letters or numerals forming a circle or a circumferenceLettres ou chiffres formant un cercle ou une circonférence
27 . 1 . 25
Letters or numerals forming some other geometrical figureLettres ou chiffres formant une autre figure géométrique
Trademark usage description
pharmaceutical preparations for treatment of eye disease. scientific research and development services in the field of biotechnology.11
11
2090230
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 22 on 18th Oct 2024 | Search Recorded |
Submitted for opposition 20 on 18th Oct 2024 | Examiner's First Report |
Submitted for opposition 287 on 29th Jun 2022 | Pre-Assessment Letter Sent |
Submitted for opposition 30 on 09th Mar 2021 | Filed |
Submitted for opposition 1 on 09th Mar 2021 | Created |
Submitted for opposition 31 on 09th Mar 2021 | Formalized |